Skip to content

A Cohort Study 0n The Effect 0f Traditional Chinese Medicine On Quality 0f Life In Amyotrophic Lateral Sclerosis Patients

A Cohort Study 0n The Effect 0f Traditional Chinese Medicine On Quality 0f Life In Amyotrophic Lateral Sclerosis Patients

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000037353
Enrollment
Unknown
Registered
2020-08-28
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-10-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amyotrophic lateral sclerosis

Interventions

Sponsors

Shuguang Hospital affiliated to Shanghai University of Traditional Chinese medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All voluntarily registered patients with lateral sclerosis of muscular dystrophy. (1) There must be: A: evidence of clinical, electrophysiological or neuropathic degeneration of inferior motor neurons; B: Clinical examination confirmed the degeneration of upper motor neurons; C: Symptoms that develop gradually in one area or from one area to another are detected by history or examination. (2) At the same time: A: signs of degeneration of lower motor neurons and/or upper motor neurons that can be explained by electrophysiological or pathological evidence of other diseases; B: Neuroimaging evidence of other diseases can explain the clinical and electrophysiological characteristics. 2) Clinical diagnostic study of ALS: Medical history, physical examination and neurological examination should detect clinical evidence of upper and lower motor neuron injury in four areas of the central nervous system (brain stem, neck, chest and lumbosacral medulla), and perform neuroelectrophysiological, neuroimaging and clinical laboratory tests according to clinical indications, excluding other diseases.

Exclusion criteria

Exclusion criteria: Patients who do not meet the diagnosis of sclerosis on the side of muscular atrophy

Design outcomes

Primary

MeasureTime frame
Amyotrophic lateral sclerosis scale for patients with amyotrophic lateral sclerosis before and after treatment;Amyotrophic lateral sclerosis scale;

Secondary

MeasureTime frame
Tracheotomy time;Time of death;

Countries

China

Contacts

Public ContactXuying Zhu

Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine

13651800066@163.com+86 13651800066

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026